Loading...
Organisations source: ARIS

University of Ljubljana, Faculty of Pharmacy

Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   

Code Science Field
B740  Biomedical sciences  Pharmacological sciences, pharmacognosy, pharmacy, toxicology 
T410  Technological sciences  Pharmaceuticals and related technologies 
T390  Technological sciences  Polymer technology, biopolymers 
P310  Natural sciences and mathematics  Proteins, enzymology 
P390  Natural sciences and mathematics  Organic chemistry 

Code Description
Research 
Education 
Evaluation (rules)
source: COBISS
Points
48,354.53
A''
6,552.61
A'
22,379.5
A1/2
31,118.46
CI10
55,009
CImax
1,105
h10
92
A1
167.9
A3
48.19
Data for the last 5 years (citations for the last 10 years) on May 29, 2024; A3 for period 2018-2022
Database Linked records Citations Pure citations Average pure citations
WoS 3,040  70,996  62,385  20.52 
Scopus 3,175  79,517  70,314  22.15 
Research groups (2)
no. Code Name of group Responsible person No. of publicationsNo. of publications
1. 0787-001  Chair of Pharmaceutical Technology  PhD Albin Kristl   5,462 
2. 0787-002  Chair for Pharmaceutical Chemistry  PhD Stanislav Gobec   12,214 
Researchers (158)
no. Code Name and surname Research area Status No. of publicationsNo. of publications
1. 58954  Boštjan Adamlje  Pharmacy  Researcher 
2. 15490  PhD Pegi Ahlin Grabnar  Pharmacy  Researcher  212 
3. 21456  PhD Marko Anderluh  Pharmacy  Researcher  371 
4. 54786  Ana Baumgartner  Pharmacy  Researcher  24 
5. 24257  PhD Aleš Berlec  Pharmacy  Researcher  222 
6. 38497  PhD Maja Bjelošević Žiberna  Pharmacy  Researcher  80 
7. 11124  PhD Marija Bogataj  Pharmacy  Researcher  374 
8. 32694  PhD Katarina Bolko Seljak  Pharmacy  Researcher  55 
9. 00781  PhD Borut Božič  Microbiology and immunology  Researcher  601 
10. 23598  PhD Tomaž Bratkovič  Pharmacy  Researcher  238 
11. 53656  PhD Aleša Bricelj  Pharmacy  Researcher  33 
12. 57938  Tilen Burnik  Pharmacy  Researcher 
13. 26227  Manja Cedilnik    Junior expert or technical associate 
14. 17432  Margareta Cof    Junior expert or technical associate 
15. 37459  PhD Andrej Emanuel Cotman  Chemistry  Researcher  57 
16. 19281  PhD Zdenko Časar  Chemistry  Researcher  166 
17. 34096  PhD Nanča Čebron Lipovec  Pharmacy  Researcher  73 
18. 15099  PhD Darko Černe  Pharmacy  Researcher  261 
19. 16362  PhD Saša Čučnik  Microbiology and immunology  Researcher  387 
20. 31716  PhD Andreja Čufar  Microbiology and immunology  Researcher  295 
21. 54784  Jaka Dernovšek  Pharmacy  Researcher  29 
22. 19785  PhD Bojan Doljak  Pharmacy  Researcher  262 
23. 53585  PhD Črt Dragar  Pharmacy  Researcher  38 
24. 21455  PhD Rok Dreu  Pharmacy  Researcher  292 
25. 57579  Ivan Džajić  Pharmacy  Researcher 
26. 52168  Tjaša Felicijan  Pharmacy  Researcher  26 
27. 55890  Svit Ferjančič Benetik  Pharmacy  Researcher 
28. 31879  Petra Ferkov    Junior expert or technical associate 
29. 57970  MSc Marzia Fois  Pharmacy  Researcher 
30. 34841  Maja Frelih  Forestry, wood and paper technology  Junior expert or technical associate  16 
31. 26512  PhD Rok Frlan  Pharmacy  Researcher  113 
32. 18700  Valerija Garb    Junior expert or technical associate 
33. 11789  PhD Mirjana Gašperlin  Pharmacy  Researcher  600 
34. 28446  PhD Ilija German Ilić  Pharmacy  Researcher  143 
35. 50713  Katja Glinšek  Pharmacy  Researcher 
36. 58034  Klemen Gnidovec  Pharmacy  Researcher 
37. 32034  PhD Martina Gobec  Oncology  Researcher  180 
38. 15284  PhD Stanislav Gobec  Pharmacy  Researcher  842 
39. 29887  PhD Mirjam Gosenca Matjaž  Pharmacy  Researcher  142 
40. 16107  PhD Iztok Grabnar  Pharmacy  Researcher  440 
41. 58037  Nina Gradišek  Pharmacy  Researcher 
42. 51457  Blaž Grilc  Pharmacy  Researcher  39 
43. 55103  Nina Katarina Grilc  Pharmacy  Researcher  17 
44. 52093  PhD Andrej Grobin  Pharmacy  Researcher  14 
45. 52379  PhD Samo Guzelj  Pharmacy  Researcher  22 
46. 57412  Danijela Herga  Pharmacy  Researcher 
47. 54604  Luka Hiti  Pharmacy  Researcher  10 
48. 29979  PhD Nejc Horvat  Pharmacy  Researcher  88 
49. 55893  Selena Horvat  Pharmacy  Researcher 
50. 32036  PhD Martina Hrast Rambaher  Pharmacy  Researcher  139 
51. 17433  Tatjana Hrovatič    Junior expert or technical associate 
52. 24400  PhD Janez Ilaš  Pharmacy  Researcher  250 
53. 26496  PhD Žiga Jakopin  Pharmacy  Researcher  195 
54. 56838  Špela Janež  Pharmacy  Researcher 
55. 34670  PhD Biljana Janković  Pharmacy  Researcher  137 
56. 55891  Nuša Japelj  Pharmacy  Researcher 
57. 34930  PhD Janja Jazbar  Pharmacy  Researcher  46 
58. 01302  PhD Matjaž Jeras  Biotechnology  Researcher  364 
59. 56841  Ana Jug  Pharmacy  Researcher 
60. 27741  PhD Simona Jurković Mlakar  Pharmacy  Researcher  85 
61. 18619  PhD Maša Kandušer  Pharmacy  Researcher  161 
62. 21459  PhD Nataša Karas Kuželički  Pharmacy  Researcher  175 
63. 56840  Vid Kavaš  Pharmacy  Researcher 
64. 20370  PhD Mojca Kerec Kos  Pharmacy  Researcher  246 
65. 18699  Mojca Keržan    Junior expert or technical associate 
66. 21692  Irena Klančnik Mavec    Junior expert or technical associate 
67. 36438  PhD Damijan Knez  Pharmacy  Researcher  203 
68. 29281  PhD Lea Knez  Pharmacy  Researcher  201 
69. 24402  PhD Petra Kocbek  Pharmacy  Researcher  296 
70. 26495  PhD Nina Kočevar Glavač  Pharmacy  Researcher  239 
71. 55892  Anja Kodila  Pharmacy  Researcher 
72. 35028  PhD Ana Kodrič  Pharmacy  Researcher  54 
73. 30815  PhD Meta Kokalj Ladan  Pharmacy  Researcher  33 
74. 17434  Mihaela Kolarev    Junior expert or technical associate 
75. 04648  PhD Janko Kos  Biotechnical sciences  Researcher  1,162 
76. 20374  PhD Mitja Kos  Pharmacy  Researcher  485 
77. 33908  PhD Urban Košak  Pharmacy  Researcher  58 
78. 55572  PhD Alen Krajnc  Pharmacy  Researcher  32 
79. 15460  PhD Samo Kreft  Pharmacy  Researcher  779 
80. 11122  PhD Albin Kristl  Pharmacy  Researcher  350 
81. 53673  Nika Kržišnik  Pharmacy  Researcher  39 
82. 32037  PhD Zoran Lavrič  Pharmacy  Researcher  67 
83. 17430  Nevenka Lilik    Junior expert or technical associate 
84. 24399  PhD Igor Locatelli  Pharmacy  Researcher  275 
85. 19649  PhD Marija Nika Lovšin  Microbiology and immunology  Researcher  126 
86. 57531  David Lukić  Pharmacy  Researcher 
87. 25096  PhD Mojca Lunder  Pharmacy  Researcher  258 
88. 12189  PhD Janja Marc  Metabolic and hormonal disorders  Researcher  712 
89. 34223  PhD Tijana Markovič  Pharmacy  Researcher  58 
90. 58033  Peter Mastnak-Sokolov  Pharmacy  Researcher 
91. 53777  Mateja Matjaž    Junior expert or technical associate 
92. 53584  PhD Anže Meden  Pharmacy  Researcher  43 
93. 36440  PhD Ana Mitrović  Pharmacy  Researcher  114 
94. 12443  PhD Irena Mlinarič Raščan  Pharmacy  Researcher  534 
95. 23419  PhD Janez Mravljak  Pharmacy  Researcher  203 
96. 19061  PhD Aleš Obreza  Pharmacy  Researcher  331 
97. 32693  PhD Jasna Omersel  Pharmacy  Researcher  89 
98. 10691  PhD Joško Osredkar  Human reproduction  Researcher  1,308 
99. 18154  PhD Barbara Ostanek  Metabolic and hormonal disorders  Researcher  189 
100. 28861  PhD Stane Pajk  Pharmacy  Researcher  189 
101. 57678  Emiliano Paradiso  Pharmacy  Researcher 
102. 19170  PhD Urša Pečar Fonović  Pharmacy  Researcher  145 
103. 37648  Katja Perc    Junior expert or technical associate  11 
104. 26104  Peter Peršolja  Pharmacy  Researcher 
105. 19317  PhD Lucija Peterlin Mašič  Pharmacy  Researcher  408 
106. 55894  Martina Piga  Pharmacy  Researcher  11 
107. 32035  PhD Anja Pišlar  Biotechnology  Researcher  167 
108. 14935  PhD Odon Planinšek  Pharmacy  Researcher  440 
109. 52446  Timeja Planinšek Parfant  Pharmacy  Researcher  37 
110. 51651  PhD Tina Vida Plavec  Biotechnology  Researcher  52 
111. 37548  PhD Tanja Potrč  Pharmacy  Researcher  43 
112. 56839  Monika Prašnikar  Pharmacy  Researcher 
113. 52376  PhD Matic Proj  Pharmacy  Researcher  65 
114. 55895  Edvin Purić  Pharmacy  Researcher 
115. 30708  PhD Petra Ratajc  Pharmacy  Researcher  16 
116. 56837  Nina Ravbar  Pharmacy  Researcher 
117. 29603  PhD Matjaž Ravnikar  Pharmacy  Researcher  71 
118. 23549  PhD Robert Roškar  Pharmacy  Researcher  305 
119. 58036  Žana Rus  Metabolic and hormonal disorders  Researcher 
120. 54785  Katja Schoss  Pharmacy  Researcher  31 
121. 58611  PhD Daniela Secci  Pharmacy  Researcher 
122. 19786  Majda Sirnik    Junior expert or technical associate 
123. 57309  Tjaša Slokan  Pharmacy  Researcher 
124. 55140  Lara Smrdel  Pharmacy  Researcher  13 
125. 08519  PhD Marija Sollner Dolenc  Pharmacy  Researcher  660 
126. 30816  PhD Izidor Sosič  Pharmacy  Researcher  254 
127. 25490  PhD Matej Sova  Pharmacy  Researcher  163 
128. 34299  PhD Barbara Sterle Zorec  Pharmacy  Researcher  49 
129. 52378  Nika Strašek Benedik  Pharmacy  Researcher  27 
130. 29982  PhD Alenka Šmid  Pharmacy  Researcher  123 
131. 07849  PhD Borut Štrukelj  Biochemistry and molecular biology  Researcher  1,127 
132. 26198  PhD Urban Švajger  Microbiology and immunology  Researcher  204 
133. 33335  PhD Eva Tavčar  Pharmacy  Researcher  80 
134. 35325  Martina Tekavec    Junior expert or technical associate 
135. 38166  PhD Žane Temova Rakuša  Pharmacy  Researcher  46 
136. 57679  PhD Mateja Toma  Pharmacy  Researcher 
137. 28334  PhD Tihomir Tomašić  Pharmacy  Researcher  375 
138. 58038  Gašper Tomšič  Pharmacy  Researcher  11 
139. 53933  Armando Tratenšek  Pharmacy  Researcher 
140. 23420  PhD Jurij Trontelj  Pharmacy  Researcher  262 
141. 34512  PhD Dunja Urbančič  Pharmacy  Researcher  62 
142. 01878  PhD Uroš Urleb  Pharmacy  Researcher  381 
143. 54024  Mercedes Vitek  Pharmacy  Researcher  23 
144. 18155  PhD Tomaž Vovk  Pharmacy  Researcher  232 
145. 53726  Lucija Ana Vrščaj  Metabolic and hormonal disorders  Researcher  32 
146. 54787  Veronika Weiss  Pharmacy  Researcher 
147. 53670  PhD Živa Zajec  Pharmacy  Researcher  15 
148. 17438  Damijana Zalar    Junior expert or technical associate 
149. 53234  MSc Maja Zalokar  Natural sciences and mathematics  Junior expert or technical associate  44 
150. 18633  PhD Anamarija Zega  Pharmacy  Researcher  186 
151. 53870  Anže Zidar  Pharmacy  Researcher  34 
152. 28905  PhD Nace Zidar  Pharmacy  Researcher  220 
153. 32306  PhD Janja Zupan  Metabolic and hormonal disorders  Researcher  110 
154. 58035  Ana Zupančič  Pharmacy  Researcher 
155. 36439  PhD Špela Zupančič  Pharmacy  Researcher  128 
156. 26226  PhD Alenka Zvonar Pobirk  Pharmacy  Researcher  212 
157. 22659  PhD Simon Žakelj  Pharmacy  Researcher  162 
158. 29416  PhD Lovro Žiberna  Neurobiology  Researcher  245 
Research projects (181) Legend
no. Code Title Period Responsible person No. of publicationsNo. of publications
1. N1-0331  A double whammy for the NF-κB signalling pathway: development of TAK1 and IKKβ degraders against inflammation-driven diseases  1/1/2024 - 12/31/2027  PhD Izidor Sosič   254 
2. N1-0363  Bisphenol A substitutes: health risks to the endocrine and cardiovascular systems (Acronim: BPAsubRisk)  3/1/2024 - 2/28/2027  PhD Marija Sollner Dolenc   660 
3. J1-50038  New Hsp90 Inhibitor-based Therapies for Ewing Sarcoma  1/1/2024 - 12/31/2026  PhD Tihomir Tomašić   375 
4. J1-50023  3DfluorCO - Three-dimensional fluorine-based carbonyl bioisosteres: asymmetric synthesis and validation  10/1/2023 - 9/30/2026  PhD Andrej Emanuel Cotman   1,051 
5. J3-50099  A novel therapeutic strategy for allergic diseases based on epitope-paratope blocking  10/1/2023 - 9/30/2026  PhD Peter Korošec   1,414 
6. J3-50123  Bacterial Biofilm Formation Inhibitors: A Novel Approach to Combat Antimicrobial Resistance  10/1/2023 - 9/30/2026  PhD Martina Hrast Rambaher   2,215 
7. J1-50039  Breaking the Walls: Development of Inhibitors of D,D- and L,D-Transpeptidases  10/1/2023 - 9/30/2026  PhD Stanislav Gobec   3,790 
8. J1-50037  Development of CDK1-selective degraders for the treatment of T-cell malignancies  10/1/2023 - 9/30/2026  PhD Izidor Sosič   1,103 
9. L7-50044  Efficacy and safety of dietary supplementation in targeting sleep quality: an evidence-based approach for supporting informed choices  10/1/2023 - 9/30/2026  PhD Igor Pravst   3,714 
10. J3-50116  Matters of the heart: elucidating the cardiotoxic mechanism of proteasome inhibitors  10/1/2023 - 9/30/2026  PhD Martina Gobec   2,219 
11. J4-50139  Valorization of Himalayan balsam (Impatiens glandulifera Royle) waste to design bioactive extracts with a potential protective activity on the human vascular system  10/1/2023 - 9/30/2026  PhD Alen Albreht   1,344 
12. BI-FR/24-25-PROTEUS-003  Antibiotic adjuvants: translocation of boron-containing β-lactamase inhibitors via OmpF/OmpC porin channels and their subcellular quantification in Enterobacteria  1/1/2024 - 12/31/2025  PhD Alen Krajnc   32 
13. BI-FR/24-25-PROTEUS-002  Identification of low molecular weight inhibitors for the development of new antibacterial drugs  1/1/2024 - 12/31/2025  PhD Rok Frlan   113 
14. N1-0277  Research of multifunctional compounds targeting neuroinflammation and cholinergic deficit in Alzheimer's disease  1/1/2023 - 12/31/2025  PhD Stanislav Gobec   1,068 
15. L4-4564  Biotehnological potential of selected microorganisms from Sečovlje Saltpans for application in cosmetics products  10/1/2022 - 9/30/2025  PhD Ana Rotter   2,757 
16. J1-4417  Development of novel small molecule Toll-like receptors 7 and 8 modulators for cancer immunotherapy  10/1/2022 - 9/30/2025  PhD Matej Sova   3,938 
17. J1-4402  Dynamical model of a type II DNA topoisomerase biological nanomachine and design of catalytic inhibitors  10/1/2022 - 9/30/2025  PhD Andrej Perdih   2,637 
18. J1-4400  Evaluation of transient protein states  10/1/2022 - 9/30/2025  PhD Simona Golič Grdadolnik   3,237 
19. J3-4499  MECHANISMS OF RESPONSE TO INTERLEUKIN 12/23 BLOCKERS IN ULCERATIVE COLITS – TOWARDS PERSONALIZED MEDICINE  10/1/2022 - 9/30/2025  PhD David Drobne   2,557 
20. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy  10/1/2022 - 9/30/2025  PhD Lucija Peterlin Mašič   6,075 
21. J3-4527  Muscle cell secretom and bone cells interplay in osteosarcopenia (MiKOSA)  10/1/2022 - 9/30/2025  PhD Janja Marc   3,568 
22. J7-4418  Nanofibers for codelivery of selected microbiota cocktails and antimicrobials for local treatment of vaginal infections  10/1/2022 - 9/30/2025  PhD Špela Zupančič   5,285 
23. J4-4556  New biofertilization approach based on the microbial multispecies biocatalytic aggregates  10/1/2022 - 9/30/2025  PhD Tomaž Rijavec   6,361 
24. J3-4496  Next-generation adjuvants for mucosal vaccines  10/1/2022 - 9/30/2025  PhD Žiga Jakopin   1,202 
25. J1-4414  ProBiS-Fold approach for binding site detection for whole structural human proteome in drug discovery  10/1/2022 - 9/30/2025  PhD Dušanka Janežič   2,066 
26. L2-4455  Quantitative light scattering spectroscopy as a process analytical technology in pharmaceutical manufacturing  10/1/2022 - 9/30/2025  PhD Franjo Pernuš   2,621 
27. J2-4480  Removal of selected antimicrobials by plasma-cavitation hybrid technology from water matrices of varying complexity (Causma)  10/1/2022 - 9/30/2025  PhD Martin Petkovšek   2,711 
28. J7-4420  Selective mechanical removal of bacterial biofilms by conjugated magnetic nanoparticles  10/1/2022 - 9/30/2025  PhD Aleš Berlec   3,835 
29. BI-RS/23-25-016  Confronting multidrug-resistant Acinetobacter baumanii infection by DNA gyrase and topoisomerase inhibitors  7/1/2023 - 6/30/2025  PhD Žiga Jakopin   195 
30. BI-RS/23-25-018  The use of active cosmetic ingredients from botanical origin for lowering the synthetic preserves in cosmetic products  7/1/2023 - 6/30/2025  PhD Samo Kreft   779 
31. BI-HR/23-24-031  Development of nanomedicines with poorly soluble drugs for ocular application  4/1/2023 - 3/31/2025  PhD Petra Kocbek   296 
32. BI-HR/23-24-032  Evaluation of harmine analogues as potential Hsp90 inhibitors against pediatric sarcomas  4/1/2023 - 3/31/2025  PhD Tihomir Tomašić   375 
33. BI-TR/22-24-007  Antimicrobial activity evaluation of natural and synthetic cinnamic acid derivatives against human and fish pathogens and their potential use as additives in fish feed  1/1/2023 - 12/31/2024  PhD Matej Sova   163 
34. BI-DE/23-24-011  Computer-aided design, synthesis and biological evaluation of Toll-like receptor 8 modulators  1/1/2023 - 12/31/2024  PhD Matej Sova   163 
35. BI-FR/23-24-PROTEUS-002  Development of effective reactivators of organophosphate-inhibited butyrylcholinesterase  1/1/2023 - 12/31/2024  PhD Damijan Knez   203 
36. BI-AT/23-24-008  Development of Hsp90 C-terminal domain inhibitors for the treatment of pediatric sarcomas  1/1/2023 - 12/31/2024  PhD Tihomir Tomašić   375 
37. BI-DE/23-24-009  New mitochondrial ion channels Kv1.3 inhibitors as inducers of apoptosis  1/1/2023 - 12/31/2024  PhD Lucija Peterlin Mašič   408 
38. BI-ME/23-24-030  Non-Alcoholic Fatty Liver Disease in adolescents and its association with oxidative stress, inflammation and genetic factors  1/1/2023 - 12/31/2024  PhD Barbara Ostanek   189 
39. J3-3079  Bactericidal nanoblades: a proof-of-concept approach for bimodal chemo-mechanical eradication of persistent biofilms  12/1/2021 - 11/30/2024  PhD Stane Pajk   2,411 
40. Z1-4405  Development of new antibiotics simultaneously targeting beta-lactamases and penicillin-binding proteins  10/1/2022 - 9/30/2024  PhD Alen Krajnc   32 
41. J1-3021  A synthetic biofilm-based platform for studying and development of new antibiofilm strategies  10/1/2021 - 9/30/2024  PhD Iztok Dogša   1,416 
42. J3-3062  Autologous immunohybridomas and advanced treatment of stage II and III triple-negative breast cancer  10/1/2021 - 9/30/2024  PhD Matjaž Jeras   2,530 
43. J3-3071  Cathepsins B and X in breast cancer stem cells – molecular targets and relevance for antitumor therapy  10/1/2021 - 9/30/2024  PhD Ana Mitrović   2,666 
44. J4-3092  Development of biologically active and chemically stable xanthophylls based on a sustainable esterification of xanthophylls from renewable natural resources  10/1/2021 - 9/30/2024  PhD Alen Albreht   1,391 
45. L1-3160  Development of highly concentrated protein formulations and evaluation of absorption kinetics after subcutaneous administration  10/1/2021 - 9/30/2024  PhD Iztok Grabnar   2,956 
46. J1-3031  Development of new inhibitors of bacterial topoisomerases to overcome antimicrobial resistance  10/1/2021 - 9/30/2024  PhD Nace Zidar   1,037 
47. J2-3043  Exploitation of the magneto-mechanical effect in the treatment of neurodegenerative diseases  10/1/2021 - 9/30/2024  PhD Slavko Kralj   4,419 
48. J1-3030  MTAvsAMR: new MultiTargeting Antibiotics against AntiMicrobial Resistance  10/1/2021 - 9/30/2024  PhD Lucija Peterlin Mašič   960 
49. J4-3096  Recombinant probiotics as bio-alternative antimicrobial approach against Clostridioides difficile  10/1/2021 - 9/30/2024  PhD Borut Štrukelj   3,054 
50. L3-3177  Safety evaluation of cannabidiols and implications for public health and consumers behaviour  10/1/2021 - 9/30/2024    4,852 
51. J1-3018  Smart probes for ex vivo assay-based early prediction of Alzheimer disease  10/1/2021 - 9/30/2024  PhD Janez Košmrlj   2,217 
52. L3-3176  The Role and Potential Application of Immunomodulatory Mesenchymal Stem Cells in COVID- 19 Disease  10/1/2021 - 9/30/2024  PhD Janja Zupan   3,410 
53. BI-US/22-24-182  Characterization of NOD2 receptor ligand binding  7/1/2022 - 6/30/2024  PhD Žiga Jakopin   195 
54. BI-US/22-24-004  Optimization of selective butyrylcholine esterase inhibitors as potential therapeutic agents for heroin abuse therapy  7/1/2022 - 6/30/2024  PhD Damijan Knez   203 
55. N1-0172  Fotokemijski pristop za odkrivanje naprednih ATP-kompetitivnih prob z zaviralnim delovanjem na Topoizomerazo IIalfa (Slovene)  1/1/2021 - 12/31/2023  PhD Janez Ilaš   743 
56. N1-0169  Kovalentni pristop k boju proti bakterijski rezistenci (Slovene)  1/1/2021 - 12/31/2023  PhD Stanislav Gobec   1,190 
57. J3-2517  Development of innate immune receptor-targeting chimeras as custom-tailored vaccine adjuvants  9/1/2020 - 12/31/2023  PhD Žiga Jakopin   2,215 
58. J1-2484  Development of antibacterial compounds targeting validated enzymes in peptidoglycan biosynthesis  9/1/2020 - 8/31/2023  PhD Stanislav Gobec   3,886 
59. J7-2603  EFFICACY OF BACTERIOPHAGES FOR TREATEMENT OF EXTRACELULAR AND INTRACELULAR BACTERIAL INFECTIONS OF IMPLANTANTS  9/1/2020 - 8/31/2023  PhD Aleš Podgornik   2,309 
60. J3-2521  Inflammatory process in interstitial cystitis and evaluation of the influence of cannabinoid receptor agonists in urinary bladder - from cells to patients  9/1/2020 - 8/31/2023  PhD Peter Veranič   3,832 
61. J1-2483  Radiopharmaceuticals with antagonistic activity on CCK2R  9/1/2020 - 8/31/2023  PhD Marko Anderluh   1,058 
62. J3-2518  Role of APOBEC proteins in the oncogenesis of HPV viruses  9/1/2020 - 8/31/2023  PhD Martina Bergant Marušič   1,204 
63. J1-2485  The kiss of death for key apoptosis players: development of BCL-2 and BAX PROTACs  9/1/2020 - 8/31/2023  PhD Izidor Sosič   958 
64. J1-1717  Development of novel Hsp90 inhibitors with anticancer activity  7/1/2019 - 6/30/2023  PhD Tihomir Tomašić   1,900 
65. J3-1745  Elucidating the role of immunoproteasome in platelet-driven immune response  7/1/2019 - 6/30/2023  PhD Martina Gobec   1,128 
66. J3-1749  Mesenchymal stem cells-the keepers of tissue endogenous regenerative capacity facing up to aging of the musculoskeletal system  7/1/2019 - 6/30/2023  PhD Janja Zupan   2,360 
67. J1-1709  Strukturni vpogled v mehanizem tvorbe površine bakterije Clostridium difficile  7/1/2019 - 6/30/2023  PhD Dušan Turk   2,165 
68. J4-1778  Exploitation of a virus-borne small protein to combat antibiotic resistance in Staphylococcus aureus  7/1/2019 - 12/31/2022  PhD Matej Butala   3,395 
69. N1-0098  Discovery and mechanism of action of novel hEag1 potassium channel lead molecules with anti-cancer activity  1/1/2019 - 12/31/2022  PhD Lucija Peterlin Mašič   887 
70. V4-2038  DNA vaccine and peptide inhibitors against SARS-CoV-2  10/1/2020 - 9/30/2022  PhD Roman Jerala   8,248 
71. Z1-2635  Modular asymmetric total synthesis of bioactive multi-chiral natural products  9/1/2020 - 8/31/2022  PhD Andrej Emanuel Cotman   57 
72. J3-1759  Comprehensive characterization of GWAS hits – pipeline to novel drug targets for anabolic treatment of osteoporosis (GWASforAna)  7/1/2019 - 6/30/2022  PhD Janja Marc   4,773 
73. J4-1776  Improvement of immunotherapeutic potential of NK cells through modulation of cystatin F  7/1/2019 - 6/30/2022  PhD Janko Kos   2,947 
74. J1-1715  Protein interaction atlas for prediction of genetic variations involved in drug interactions and disease development  7/1/2019 - 6/30/2022  PhD Dušanka Janežič   2,571 
75. J4-1767  Selective extraction of high value molecules from forest products processing residues in the speciality chemicals sector  7/1/2019 - 6/30/2022  PhD Andreja Kutnar   4,070 
76. J3-9256  Development of NOD2 agonists and dual NOD2/TLR7 agonistic conjugates as novel vaccine adjuvants  7/1/2018 - 6/30/2022  PhD Žiga Jakopin   2,814 
77. J1-9194  Nanomedicines with antibiotics and probiotics for local treatment of periodontal disease  7/1/2018 - 6/30/2022  PhD Julijana Kristl   3,440 
78. Z1-1859  Targeted covalent inhibitors: inhibiting monoamine oxidase through non-catalytic amino-acid residues  7/1/2019 - 6/30/2021  PhD Damijan Knez   203 
79. J3-9267  Inhibition of cathepsin X activity as a novel strategy for the treatment of Parkinson's disease   7/1/2018 - 6/30/2021  PhD Anja Pišlar   2,749 
80. J1-9192  New anticancer leads for emerging cancer target potassium ion channels hEag1 and its validation in lymphoma tumors   7/1/2018 - 6/30/2021  PhD Lucija Peterlin Mašič   2,208 
81. J4-9327  Targeting, imaging and treating of colorectal cancer with safe theranostic bacteria  7/1/2018 - 6/30/2021  PhD Aleš Berlec   2,478 
82. NC-0009  Development of new carbamate-based imaging probes for cholinesterases  4/1/2019 - 3/31/2021  PhD Stanislav Gobec   1,063 
83. V1-1914  Selection and preparation of a dossier potentially neurotoxic chemical using in silico methods for the purpose of implementing the European chemical legislation REACH  11/1/2019 - 10/31/2020  PhD Marjan Vračko - Grobelšek   929 
84. N1-0068  Identification of non-peptidic inhibitors of the immunoproteasome using fragment based drug discovery methods  11/1/2017 - 10/31/2020  PhD Stanislav Gobec   1,827 
85. Z1-9195  Butyrylcholinesterase inhibitors for alleviating symptoms of Alzheimer's disease  7/1/2018 - 6/30/2020  PhD Urban Košak   58 
86. NC-0004  NOBIL - Novel Biomarkers in Leukemia  5/1/2018 - 4/30/2020  PhD Irena Mlinarič Raščan   778 
87. J4-8227  Cathepsin X inhibitors impair the resistence of tumor cells to antiprotease therapy   5/1/2017 - 4/30/2020  PhD Janko Kos   4,580 
88. L1-8157  Development of multifunctional compounds for treatment of Alzheimer's disease  5/1/2017 - 4/30/2020  PhD Stanislav Gobec   4,717 
89. J1-8145  Dynamic aspect of ligand-protein binding  5/1/2017 - 4/30/2020  PhD Simona Golič Grdadolnik   1,771 
90. J1-8140  Endocrine disrupting and genotoxic potential of protein kinase inhibitors: relevance for environmental hazard in zdravje ljudi  5/1/2017 - 4/30/2020  PhD Metka Filipič   3,759 
91. J1-8152  Inhibition of Staphylococcus aureus cell wall remodeling  5/1/2017 - 4/30/2020  PhD Dušan Turk   1,993 
92. J3-8207  New frontiers in folate supplementation in obstetrics and gynaecology (NFFS OB-GYN)  5/1/2017 - 4/30/2020  PhD Ksenija Geršak   4,985 
93. J3-8210  Potential of low, sub-therapeutic doses of statins and sartans in primary and secondary cardiovascular disease prevention  5/1/2017 - 4/30/2020  PhD Mirza Šabovič   2,437 
94. V4-1605  The use of hop products for organic control of varroa (Varroa destructor)  10/1/2016 - 9/30/2019  PhD Iztok Jože Košir   3,127 
95. Z1-8158  Discovery of new inhibitors of bacterial peptidoglycan biosynthesis enzymes MurA and MurB  5/1/2017 - 4/30/2019  PhD Marko Jukič   171 
96. L2-7550  Elecrospun nanofibrous materials for solid state drug delivery system  3/1/2016 - 2/28/2019  PhD Igor Emri   4,440 
97. J4-7640  Electrostatic immobilisation of bacterial cells and effects on their physiology  3/1/2016 - 2/28/2019  PhD Aleš Lapanje   7,078 
98. J3-7245  Identification of new expression regulators of RANKL, a key molecule not only in bone remodelling  1/1/2016 - 12/31/2018  PhD Janja Marc   2,700 
99. J1-7302  Nanotheranostics based on magneto-responsive materials  1/1/2016 - 12/31/2018  PhD Petra Kocbek   3,924 
100. J1-7515  Receptors for toxins of plant pathogens  1/1/2016 - 12/31/2018  PhD Gregor Anderluh   3,846 
101. J1-7479  Structural insight into iodine metabolism  1/1/2016 - 12/31/2018  PhD Dušan Turk   1,775 
102. J3-7494  Tunneling nanotubes for innovative urinary bladder cancer treatments  1/1/2016 - 12/31/2018  PhD Mateja Erdani Kreft   7,096 
103. V3-1636  New psychoactive substances monitoring system in Slovenia (acronym SONDA)  10/1/2016 - 9/30/2018  PhD Miran Brvar   1,496 
104. Z1-7181  Optimization of nitroxoline-based inhibitors of cathepsin B as potential drugs for the treatment of cancer  1/1/2016 - 12/31/2017  PhD Izidor Sosič   254 
105. L1-6745  Combating bacterial resistance: optimisation of bacterial cell wall biosynthesis inhibitors  7/1/2014 - 6/30/2017  PhD Stanislav Gobec   3,256 
106. J1-6743  Computational tools development for modeling of pharmaceutically interesting molecules  7/1/2014 - 6/30/2017  PhD Dušanka Janežič   2,729 
107. J1-6744  Development of Molecularly Imprinted Polymers and their application in environmental and bio-analysis  7/1/2014 - 6/30/2017  PhD Tina Kosjek   4,828 
108. J1-6746  Intra-pocket-targeted nanomedicines for treatment of periodontal disease  7/1/2014 - 6/30/2017  PhD Julijana Kristl   3,907 
109. J4-6811  The role of cysteine protease inhibitors in NK cell mediated lysis of tumour cells  7/1/2014 - 6/30/2017  PhD Janko Kos   2,449 
110. J3-6792  TRANS TIO Translational pharmacogenomic research of thiopurine therapy  7/1/2014 - 6/30/2017  PhD Irena Mlinarič Raščan   1,603 
111. J3-5507  ANALYSIS OF FOLATE METABOLISM BIOMARKERS IN THE RISK ASSESSMENT FOR NEURAL TUBE DEFECTS  8/1/2013 - 7/31/2016  PhD Ksenija Geršak   3,622 
112. J3-5502  Dysregulation of TDP-43 expression in amyotrophic lateral sclerosis and frontotemporal lobar degeneration  8/1/2013 - 7/31/2016  PhD Boris Rogelj   5,303 
113. J3-5511  Micro RNA – new diagnostic and therapeutic targerts in osteoporosis  8/1/2013 - 7/31/2016  PhD Janez Preželj   1,722 
114. J4-5529  Nitroxoline and its derivatives as new antitumour drugs  8/1/2013 - 7/31/2016  PhD Janko Kos   5,974 
115. J1-5450  Protein engineering of recombinant probiotic lactic acid bacteria for treatment of irritative bowel disease  8/1/2013 - 7/31/2016  PhD Borut Štrukelj   2,453 
116. Z1-5458  Design, synthesis, and evaluation of new voltage-gated sodium channels modulators  8/1/2013 - 7/31/2015  PhD Nace Zidar   220 
117. L2-4072  Complex hyperspectral system for automatic analysis and control of pharmaceutical pellet coating processes  7/1/2011 - 6/30/2014  PhD Boštjan Likar   2,259 
118. J1-4236  Design, formulation and characterization of biomimetic nanocomposite systems for effective tissue regeneration  7/1/2011 - 6/30/2014  PhD Julijana Kristl   5,063 
119. J3-4285  Development and evaluation of radiolabelled bio-molecules for targeted radionuclide therapy and imaging of neuroendocrine tumours  7/1/2011 - 6/30/2014  PhD Jurij Fettich   2,357 
120. J4-4123  Inhibitors of cysteine carboxypeptidases as regulators of autoimmune and neurodegenerative processes  7/1/2011 - 6/30/2014  PhD Janko Kos   6,342 
121. L1-4039  Preclinical development of new antibacterial drugs  7/1/2011 - 6/30/2014  PhD Stanislav Gobec   4,166 
122. J3-4313  The influence of active transport and patients' genotypes on the therapeutic outcome of chronic myeloic leukemia  7/1/2011 - 6/30/2014  PhD Albin Kristl   3,137 
123. L6-4045  Theoretical and practical Aspects of Terminology and Terminography in Connection with Internet Terminological Resources  7/1/2011 - 6/30/2014  PhD Andreja Žele   4,093 
124. J3-4220  The role of genetic polymorphisms in treatment result and occurance of side effects in children with cancer  7/1/2011 - 6/30/2014  PhD Janez Jazbec   3,361 
125. J3-4026  Transport and RNA binding of TDP-43 and FUS - implications for ALS/FTLD spectrum of neurodegenerative disease  7/1/2011 - 6/30/2014  PhD Boris Rogelj   4,632 
126. J3-3615  Pharmacogenetic approaches to research, diagnosis and therapy of leukemia  5/1/2010 - 4/30/2013  PhD Irena Mlinarič Raščan   2,129 
127. J3-2330  Genetski dejavniki pri osteoporozi (Slovene)  5/1/2009 - 4/30/2012  PhD Janja Marc   2,294 
128. J4-2212  Glivni citokromi P450, vključeni v detoksifikacijo rastlinskih obramnih spojin, kot tarče novih protiglivnih učinkovin (Slovene)  5/1/2009 - 4/30/2012  PhD Nada Kraševec   3,751 
129. J3-2356  Izrazanje in funkcionalna analiza nekodirajocih RNA pri parkinsonovi bolezni (Slovene)  5/1/2009 - 4/30/2012  PhD Boris Rogelj   4,387 
130. L3-2293  Zaščitni pleiotropni učinki nizkih odmerkov zaviralcev sistema renin-angiotenzin in statinov pri zdravi populaciji srednjih let (Slovene)  5/1/2009 - 4/30/2012  PhD Mirza Šabovič   3,698 
131. L3-0129  Cell-free nucleic acids in diagnosis of coronary atherosclerosis  2/1/2008 - 1/30/2011  PhD Darko Černe   2,047 
132. J7-0337  Formulation and characterization of fuzogenic colloidal nanoparticles for efficient drug delivery into cells  2/1/2008 - 1/30/2011  PhD Marjeta Šentjurc   1,545 
133. J3-0488  Functional analysis of non-coding RNAs in Parkinson's disease  2/1/2008 - 1/30/2011  PhD Boris Rogelj   2,351 
134. L3-0431  Genetics of breast cancer and hormone replacement therapy  2/1/2008 - 1/30/2011  PhD Ksenija Geršak   3,752 
135. J7-0474  New Report on Condition of Knowledge in Developed Societies – 30 Years after Jean-François Lyotard’s Analysisew Report on Knowledge  2/1/2008 - 1/30/2011  PhD Mladen Dolar   3,162 
136. L4-1046  NOVEL BIOTECH DRUG SUBSTANCES BY USING PHAGE DISPLAY TECHNOLOGY  2/1/2008 - 1/30/2011  PhD Borut Štrukelj   3,962 
137. J1-0957  Pharmacogenetic study of raloxifene metabolism and transport  2/1/2008 - 1/30/2011  PhD Aleš Mrhar   1,952 
138. L3-0636  Preparation and evaluation of stabilised control blood for haematology analysers in Slovenian external quality assessment scheme (SNEQAS).  2/1/2008 - 1/30/2011  PhD Milan Skitek   1,139 
139. L6-0075  Slovenian Terminology in Connection with Internet Language Resources  2/1/2008 - 1/30/2011  PhD Andreja Žele   2,922 
140. J7-9704  NQR - nondestructive method for studying of polymorphism in heteregeneous pharmaceutical systems  7/1/2007 - 6/30/2010  PhD Zvonko Trontelj   4,604 
141. J4-9425  Lectins as modulators of anti-tumour immune response  1/1/2007 - 12/31/2009  PhD Janko Kos   2,225 
142. J4-7062  Proteomics as a tool for monitoring biosynthesis processes  9/1/2005 - 8/31/2008  PhD Janko Kos   5,985 
143. J1-7363  Role of the proteolytic systems in the malignancy of brain tumour stem cells.  9/1/2005 - 8/31/2008  PhD Irena Zajc   3,444 
144. J3-7406  Thiopurine pharmacogenetics - novel diagnostics and individualized therapy   9/1/2005 - 8/31/2008  PhD Irena Mlinarič Raščan   2,601 
145. M4-0124  Prehranski dodatki za optimalno prehrano v ekstremnih razmerah (Slovene)  6/1/2006 - 11/30/2007  PhD Samo Kreft   4,025 
146. J3-6429  Genetski dejavniki reproduktivnega zdravja ženske (Slovene)  7/1/2004 - 6/30/2007  PhD Ksenija Geršak   3,395 
147. J1-6356  Use of inorganic particles for particle design and their potential application in systems with modified release  7/1/2004 - 6/30/2007  PhD Marjan Bele   2,646 
148. L1-6707  Design, synthesis and test of potencial hypolipidemic drugs with a new target  2/1/2004 - 1/30/2007  PhD Uroš Urleb   3,398 
149. L1-6711  Development of a technological procedure for preparation of biologicaly active hop extract enriched with xanthohumol  7/1/2004 - 6/30/2006  PhD Tamara Lah Turnšek   5,948 
150. Z1-6451  Mehanizem povečanja permeabilnosti sečnega mehurja s hitosanom (Slovene)  7/1/2004 - 6/30/2006  PhD Danijel Kikelj   813 
151. Z4-6096  Peptide ligands as novel biopharmaceutics by using phage display technology  2/1/2004 - 1/30/2006  PhD Borut Štrukelj   1,351 
152. L1-5267  Analysis of gene expression associated with apoptosis using microarrays  1/1/2003 - 12/31/2005  PhD Irena Mlinarič Raščan   718 
153. L3-5309  Analysis of gene expression associated with apoptosis using microarrays  1/1/2003 - 12/31/2005  PhD Irena Mlinarič Raščan   1,131 
154. L1-5094  Determination of surface properties of solid and semisolid materials by solid and semisolid materials with inverse phase gas chromatography  1/1/2003 - 12/31/2005  PhD Stanko Srčič   2,844 
155. L3-5084  Peptidominetiki - inhibitorji koagulacije krvi in agregacije trombocitov (Slovene)  1/1/2003 - 12/31/2005  PhD Mojca Stegnar   5,549 
156. L4-4090  Optimizacija kakovosti zdravilnih rastlin (Echinacea purpurea Moench., Gentiana lutea L., Hypericum perforatum L.) v pridelovanju (Slovene)  7/1/2002 - 6/30/2005  PhD Dea Baričevič   2,415 
157. Z1-3238  Genetic and environmental risk factors for bone remodelation disturbances  7/1/2001 - 6/30/2004  PhD Samo Kreft   2,087 
158. J3-3395  Genetic causes of female infertility 2   7/1/2001 - 6/30/2004  PhD Ksenija Geršak   4,588 
159. J3-3314  Genetic factors and hormones in metabolic diseases  7/1/2001 - 6/30/2004  PhD Andreja Kocijančič   4,952 
160. L1-3261  Development of biologicaly active peptidomimetics  7/1/2001 - 12/31/2003  PhD Uroš Urleb   2,063 
161. V4-0476  Ekotoksikološki, rezidualni in ekonomski vidiki uporabe avermektinskih zdravil pri drobnici (Slovene)  1/1/2002 - 10/31/2003  PhD Vesna Cerkvenik Flajs   4,891 
162. L1-2129  Raziskave uporabnost proste površinske energije pri trdnih farmacevtskih sistemih (Slovene)  1/1/2000 - 6/30/2002  PhD Franc Vrečer   2,327 
163. L3-2003  Razvoj rutinskih metod za dolocanje presnovkov galaktoze in genotipizacijo galaktozemij (Slovene)  1/1/2000 - 6/30/2002  PhD Tadej Battelino   3,070 
164. L1-1381  Biofarmacevtske lastnosti, sinteza in aktivnost spojin kinolonov s kovinskimi atomi (Slovene)  1/1/1999 - 6/30/2001  PhD Albin Kristl   5,157 
165. L4-1301  Proučevanje aktualnih kužnih bolezni pri živalih z uporabo sodobnih imunoloških, biokemijskih in molekularnih metod (Slovene)  1/1/1999 - 6/30/2001  PhD Darja Barlič Maganja   8,866 
166. J2-1537  Reološke lastnosti in ostali transportni procesi hidrofilnih polimerov (Slovene)  1/1/1999 - 6/30/2001  PhD Miha Žumer   3,167 
167. J1-0572  Interakcije bioaktivnih ligandov v sistemih rastoče kompleksnosti (Slovene)  7/1/1998 - 6/30/2001  PhD Aleš Mrhar   5,601 
168. L4-0827  Tkivne kulture za proizvodnjo sekundarnih metabolitov (Slovene)  7/1/1998 - 6/30/2001  PhD Jana Žel   3,105 
169. J1-7377  Protivirusne spojine: transport in interakcije v biosistemih (Slovene)  1/1/1996 - 6/30/2001  PhD Albin Kristl   2,700 
170. J3-7880  Ugotavljanje biokemičnih in elektrofizioloških parametrov pri kronično bolnih otrocih in mladostnikih (Slovene)  1/1/1996 - 6/30/2001  PhD Ciril Kržišnik   5,701 
171. V4-9128  Uporaba rastlinske biotehnologije za varstvo rastlin (razvoj identifikacijskih metod za rastlinske patogene in ovrednotenje transgenih (Slovene)  10/1/1997 - 9/30/2000  PhD Maja Ravnikar   6,458 
172. L1-0469  Optimization of MDP and TNF analogues having therapeutic potential  7/1/1998 - 6/30/2000  PhD Anton Štalc   6,251 
173. J1-8889  Mimetics of biologically active peptides: Strategies of design and synthesis  1/1/1997 - 12/31/1999  PhD Danijel Kikelj   3,857 
174. J1-8891  Synthesis, identification, and properties of potential pharmaceuticals  1/1/1997 - 12/31/1999  PhD Andrej Petrič   1,887 
175. L1-8890  Raziskave hidrodinamsko uravnoteženih farmacevtskih oblik z nadzorovanim sproščanjem (Slovene)  1/1/1997 - 12/31/1998  PhD Franc Vrečer   1,965 
176. L4-7355  Alternativno koriščenje za slovenijo perspektivnih zdravilnih in aromatičnih rastlin in njihovo vrednotenje (Slovene)  1/1/1996 - 12/31/1998  PhD Dea Baričevič   1,665 
177. L1-7823  Lastnosti in sinteza organokovinskih spojin z biološko učinkovitostjo (Slovene)  1/1/1996 - 12/31/1998  PhD Stanislav Primožič   6,733 
178. L2-7632  Spektralno selektivne energetsko efektne prevleke za solarne namene (Slovene)  1/1/1996 - 12/31/1998  PhD Boris Orel   2,474 
179. L1-7379  Raziskave možnih implementacij dezmuramilnih analogov MDP in rekombinatnih analogov TNF-a v terapiji (Slovene)  1/1/1996 - 6/30/1998  PhD Anton Štalc   6,025 
180. J1-7053  Selektivni ligandi: sinteza, interakcije z makromolekulami in transport v biosistemih (Slovene)  1/1/1995 - 6/30/1998  PhD Aleš Mrhar   7,063 
181. J3-7200  Uporabnost kvalitativne metode za vrednotenje bolnikovega jemanja zdravil (Slovene)  1/1/1995 - 6/30/1998  PhD Jelka Šmid-Korbar   563 
ARIS research and infrastructure programmes (23) Legend
no. Code Title Period Responsible person No. of publicationsNo. of publications
1. P1-0420  Advanced immunological drugs and cell-based approaches in pharmacy  1/1/2022 - 12/31/2027  PhD Žiga Jakopin   1,251 
2. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation  1/1/2022 - 12/31/2027  PhD Stanislav Gobec   5,346 
3. P3-0314  Systemic Autoimmune diseases  1/1/2022 - 12/31/2027  PhD Katja Lakota   5,415 
4. I0-0022  The Infrastructure Program of University of Ljubljana »Network of Research and Infrastructural Centers UL (MRIC UL)«  1/1/2022 - 12/31/2027  PhD Anton Ramšak   6,043 
5. P3-0298  Genes, hormones and personality changes in metabolic disorders  1/1/2019 - 12/31/2027  PhD Andrej Janež   3,488 
6. P4-0127  Pharmaceutical biotechnology: Science for health  1/1/2019 - 12/31/2027  PhD Janko Kos   5,076 
7. P1-0189  Pharmaceutical technology: from drug delivery systems to therapeutic outcomes of medicines in children end elderly  1/1/2018 - 12/31/2027  PhD Mitja Kos   6,891 
8. I0-E011  Sofinanciranje izvajanja mednarodnega infrastrukturnega projekta EATRIS (Slovene)  1/1/2022 - 12/31/2022  PhD Irena Mlinarič Raščan   1,905 
9. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation  1/1/2015 - 12/31/2021  PhD Stanislav Gobec   6,009 
10. I0-0022  Mreža raziskovalnih infrastrukturnih centrov Univerze v Ljubljani (MRIC UL) (Slovene)  1/1/2015 - 12/31/2021  PhD Anton Ramšak   13,543 
11. P3-0298  Genes, hormones and personality changes in metabolic disorders  1/1/2015 - 12/31/2018  PhD Andrej Janež   4,861 
12. P4-0127  Pharmaceutical biotechnology: Science for Health  1/1/2015 - 12/31/2018  PhD Janko Kos   4,965 
13. P1-0189  Pharmaceutical technology: from drug delivery systems to therapeutic outcomes of medicines in children end elderly  1/1/2014 - 12/31/2017  PhD Albin Kristl   6,880 
14. P4-0127  Farmacevtska biotehnologija: znanje za zdravje (Slovene)  1/1/2009 - 12/31/2014  PhD Janko Kos   5,444 
15. P1-0208  Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin (Slovene)  1/1/2009 - 12/31/2014  PhD Danijel Kikelj   5,881 
16. P3-0298  Genes, hormones and mental changes in metabolic disorders  1/1/2009 - 12/31/2014  PhD Janez Preželj   4,588 
17. P1-0189  Farmacevtska tehnologija: od dostavnih sistemov učinkovin do terapijskih izidov zdravil pri otrocih in starostnikih (Slovene)  1/1/2009 - 12/31/2013  PhD Aleš Mrhar   6,990 
18. P3-0298  Genes, hormones and mental changes in metabolic disorders  7/1/2004 - 12/31/2008  PhD Janez Preželj   3,900 
19. P1-0208  Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin (Slovene)  1/1/2004 - 12/31/2008  PhD Danijel Kikelj   6,024 
20. P4-0127  Pharmaceutical biotechnology: man and environment  1/1/2004 - 12/31/2008  PhD Janko Kos   5,276 
21. P1-0189  Pharmaceutical technology: design, preparation and evaluation of drug delivery systems  1/1/2004 - 12/31/2008  PhD Aleš Mrhar   6,992 
22. P0-0502-0787  Farmacevtska kemija (Slovene)  1/1/1999 - 12/31/2003  PhD Danijel Kikelj   7,543 
23. P0-0501-0787  Farmacevtska tehnologija (Slovene)  1/1/1999 - 12/31/2003  PhD Aleš Mrhar   5,729 
International projects (57) source: SICRIS
no. Code Title Period Responsible person
1. HORIZON-HORIZON-HLTH-2021-ENWHLTH-03-01  Partnership for the Assesment of Risks from Chemicals  5/1/2022 - 4/30/2029   
2. HORIZON-SIMPATHIC-101080249  SIMPATHIC - Accelerating drug repurposing for rare neurological, neurometabolic and neuromuscular disorders by exploiting SIMilarities in clinical and molecular PATHology  7/1/2023 - 6/30/2028   
3. HORIZON-GlyCanDrug-101119601  GlyCanDrug - A training network on the design of precision therapeutics that target key glycan motifs implicated in cancer  12/1/2023 - 11/30/2027  PhD Marko Anderluh  
4. COST-HAPLO-iPS-CA21151    10/11/2022 - 10/10/2026   
5. COST-ADVANCE-TB-CA21164    9/29/2022 - 9/28/2026   
6. HORIZON-PROTAG-8  PROTAG-8 - Protein degraders for targeting galectin-8  9/1/2024 - 8/31/2026  PhD Marko Anderluh  
7. COST-EURESTOP-CA21145    10/6/2022 - 10/5/2025   
8. ERASMUS+-DOMINOS    1/1/2022 - 12/31/2024  PhD Mitja Kos  
9. COST-CA19132 ENABLE    10/20/2020 - 10/19/2024   
10. HORIZON-101060963 — HUMANITIES ROCK  Humanities Rock! Human(e) to Animals – Science Covers Every Being!  4/11/2021 - 12/10/2023  PhD Sašo Jerše  
11. COST-CA18103 - INNOGLY    11/13/2018 - 10/7/2023   
12. COST-CA18132 GLYCONanoPROBES  Functional Glyconanomaterials for the Development of Diagnostics and Targeted Therapeutic Probes  1/1/2018 - 9/13/2023  PhD Marko Anderluh  
13. ERASMUS+-EATRIS ADVANCE-2019-1-NL01-KA203-060286  ADVANCE - Educating the next generation of Advanced Therapy (ATMP) professionals and advancing ATMP development  11/1/2019 - 12/31/2022   
14. COST-CA17117 EVBRES  Genomics of musculoskeletal traits translational network  1/1/2018 - 12/31/2022  PhD Janja Marc  
15. COST-CA18139 GEMSTONE  Genomics of musculoskeletal traits translational network  1/1/2018 - 12/31/2022  PhD Janja Marc  
16. COST-CA17118  Identifying biomarkers through translational research for prevention and stratification of colorectal cancer  1/1/2018 - 12/31/2022  PhD Marija Sollner Dolenc  
17. COST-CA17104  New diagnostic and therapeutic tools against multidrug resistant tumors  1/1/2018 - 12/31/2022  PhD Nace Zidar  
18. Crossborder cooperation-ARTE  Advanced Regenerative Therapies Ecosystem  1/1/2017 - 12/31/2022  PhD Tilen Kranjc  
19. CELSA - Cental Europe Leuven Strategic Alliance-Generiranje nanoteles...  Generation of nanobodies against immunomodulating checkpoint receptors in glioblastoma tumor cells  10/1/2020 - 9/30/2022  PhD Ivana Jovchevska  
20. ESRR-LAKTIKA - C3330-18-952002  LAKTIKA-fractionation and processing of whey proteins and exploitation of the residue for the formulation of new functional foods and food supplements  7/1/2018 - 12/31/2021   
21. H2020-PhD4GlycoDrug-211719  Multidisciplinary European Joint Doctorate in the Design and Developmen of Glyco Drugs  1/1/2017 - 12/31/2021  PhD Marko Anderluh  
22. COST-CA16231  European Network of Vaccine Adjuvants  11/13/2017 - 11/12/2021  PhD Žiga Jakopin  
23. COST-CA16205  European Network on Understanding Gastrointestinal Absorption-related Processes  10/24/2017 - 10/23/2021  PhD Albin Kristl  
24. COST-CA16225  Realising the therapeutic potential of novel cardioprotective therapies  10/19/2017 - 10/18/2021  PhD Nace Zidar  
25. WADA - World anti-doping Agency-2017  Reliable assay for rapid detection of potentially unknown erythropoietin mimetics chemically unrelated to endogenous hormone in biological samples  1/1/2018 - 12/31/2020  PhD Borut Štrukelj  
26. COST-CA15138  European Network of Multidisciplinary Research and Translation of Autophagy knowledge (TRANSAUTOPHAGY)  4/22/2016 - 4/21/2020  PhD Žiga Jakopin  
27. COST-CA15135  Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig)  4/18/2016 - 4/17/2020   
28. The Foundation for Prader-Willi Research-2018  A transcriptome-wide approach to identifying RNA targets of the Prader-Willi locus snornas  1/1/2018 - 12/31/2019  PhD Tomaž Bratkovič  
29. COST-MP1404  Simulation and pharmaceutical technologies for advanced patient-tailored inhaled medicines (SimInhale)  5/4/2015 - 5/3/2019  PhD Stanko Srčič  
30. COST-BM1406  Ion Channels and Immune Response toward a global understanding of immune cell physiology and for new therapeutic approaches (IONCHAN-IMMUNRESPON)  3/31/2015 - 3/30/2019  PhD Nace Zidar  
31. COST-CM1406  Epigenetic Chemical Biology (EPICHEM)  3/24/2015 - 3/23/2019   
32. COST-CM1407  Challenging organic syntheses inspired by nature - from natural products chemistry to drug discovery   3/16/2015 - 3/15/2019   
33. CELSA - Cental Europe Leuven Strategic Alliance-Discovery  Discovery of new leads modulating voltage gated potassium ion channels as emerging cancer targets  1/1/2017 - 12/31/2018  PhD Lucija Peterlin Mašič  
34. H2020-EU.1.3.1-INTEGRATE-193930  Interdisciplinary Training Network for Validation of Gram-Negative Antibacterial Targets  1/1/2015 - 12/31/2018  PhD Danijel Kikelj  
35. COST-CM1307  Targeted chemotherapy towards diseases caused by endoparasites  3/12/2014 - 3/11/2018   
36. COST-MP1206  Electrospun nano-fibres for bio inspired composite materials and innovative industrial applications  5/23/2013 - 5/22/2017   
37. LIFE+-PharmDegrade  Degradation of pharmaceuticals in wastewaters from nursing homes and hospitals  1/1/2014 - 12/31/2016  PhD Albin Kristl  
38. LLP-EACEA-543516  Higher education Online: MOOCs the European Way  1/1/2013 - 12/31/2016  PhD Julijana Kristl  
39. COST-CM1201  Biomimetic Radical Chemistry  12/6/2012 - 12/5/2016  PhD Marija Sollner Dolenc  
40. H2020-EU.4.a-ARTEMIDA-197116  Advanced Regional Translation of Excellence into Medical Innovations for Delayed Aging  6/1/2015 - 5/31/2016   
41. COST-CM1106  Chemical Approaches to Targeting Drug Resistance in Cancer Stem Cells  3/28/2012 - 3/27/2016  PhD Danijel Kikelj  
42. LLP-LIAT-Pharma  Linking Industry and Academia inTeaching Pharmaceutical Developmentand Manufacture  1/1/2013 - 12/31/2015  PhD Stanko Srčič  
43. LLP-PHAR-QA  Quality Assessment of Pharmaceutical education and training (PET) in Europe  1/1/2012 - 12/31/2015  PhD Borut Božič  
44. LLP-EACEA-527194  Quality assurance in pharmacy education and training in Europe  1/1/2012 - 12/31/2015   
45. FP7-HEALTH-ORCHID-96802  Open Collaborative Model for Tuberculosis Lead Optimisation  1/1/2011 - 6/30/2015  PhD Stanislav Gobec  
46. ESS-PR12168  Nova generacija raziskovalcev ved o življenju št. OP13.2.3.1.51  1/1/2012 - 12/31/2014   
47. ESS-NGRVŽ  Znanje za prihodnost - Nova generacija raziskovalcev ved o življenju št. OP13.2.2.1.51  1/1/2012 - 12/31/2014  PhD Tomaž Bratkovič  
48. FP7-KBBE-95006  Exploring Marine Resources for Bioactive Compounds: From Discovery to Sustainable Production and Industrial Applications  8/1/2010 - 7/31/2014  PhD Danijel Kikelj  
49. COST-TD0905  Epigenetics: Bench to Bedside  6/16/2010 - 6/15/2014   
50. TEMPUS-EACEA-158897  PQPHARM - Postgraduate Qualification in Pharmacy: The way forward  1/1/2010 - 12/31/2013  PhD Stanko Srčič  
51. COST-CM0801  New drugs for neglected diseases  11/28/2008 - 11/27/2012  PhD Lucija Peterlin Mašič  
52. FP7-HEALTH-86689  Targeted Nanosystems for Improving Photodynamic Therapy and Diagnosis of Cancer  7/1/2008 - 12/31/2011  PhD Janko Kos  
53. COST-CM0602  Inhibitors of angiogenesis: design, synthesis and biological exploitation (ANGIOKEM)  6/7/2007 - 6/6/2011  PhD Danijel Kikelj  
54. FP6-LIFESCIHEALTH-EUR-INTAFAR-74098  Inhibition of new targets for fighting antibiotic resistance  1/1/2005 - 6/30/2010  PhD Stanislav Gobec  
55. COST-D34  Molecular Targeting and Drug Design in Neurological and Bacterial Diseases  6/24/2005 - 6/23/2010  PhD Danijel Kikelj  
56. FP6-MOBILITY-GALENOS EURO-PHD-73425  Towards a European PhD in Advanced Drug Delivery  10/1/2004 - 9/30/2008  PhD Julijana Kristl  
57. FP4-INCO-47290  Development of an assay for quantitating residues in meat products  3/1/1999 - 6/30/2002  PhD Slavko Pečar  
Research equipment (26)
no. Equipment name Year of purchase Purchase price (€) Responsible for equipment Classification Source of co-financing
1. 3  2020  378021  PhD Zoran Lavrič   Analytical facilities  Programs, projects and commercial resources 
2. 400 MHz NMR spektrometervisoke ločljivosti  2012  218160  PhD Marko Anderluh   Analytical facilities  Programs, projects 
3. ABI PRISM Nucleic Acid PrepStation  2002  80653  PhD Janja Marc   Genomic, transcriptomic, proteomics and metabolomics facilities  Package 11 
4. Agilent 1260 Infinity Quaternary LC  2011  51240  PhD Alenka Šmid   Analytical facilities  Projects, programs and other public resources 
5. Automated Platform for Live Cell Imaging  2006  122252  PhD Janko Kos   Cell culture facilities  Package 12 
6. BD FACSCalibur Flow Cytometer  2007  142560  PhD Janko Kos   Cell culture facilities  Package 13 
7. Chromatographic system ÄKTAexplorer 10 S  2008  82427  PhD Tomaž Bratkovič   Genomic, transcriptomic, proteomics and metabolomics facilities  Projects, programs and other public resources 
8. Čitalec mikrotitrskih plošč (Synergy H4) in robot za pipetiranje (Precision XS) Multi-Mode Microplate Reader (SINERGY H4) and robot for automatic pipetting (PRECISION XS)   2010  124979  PhD Martina Hrast Rambaher   Analytical facilities  Programs, projects and commercial resources 
9. Flow cytometer Attune NxT   2015  116441  PhD Martina Gobec   Analytical facilities  Programs, projects and commercial resources 
10. GenomeLab™ GeXP Genetic Analysis System (Beckman Coulter)  2010  95302  PhD Vid Mlakar   Analytical facilities  Projects, programs and other public resources 
11. High shear Granulator 4M8Trix  2012  54844  PhD Rok Dreu   Research facilities  Programs, projects and commercial resources 
12. HPLC Liquid chromatograph   2018  61911  PhD Zoran Lavrič     Projects, programs and other public resources 
13. Imaging flow cytometer  2019  454925  PhD Martina Gobec   Analytical facilities  Package 17 
14. Laser diffractometer  2019  84219  PhD Ilija German Ilić     Programs, projects and commercial resources 
15. Leistritz ZSE 12 HP-PH twin screw hot melt extruder for hot melt extrusion (HME) and twin screw granulation (TSG) with supporting equipment for material feed, cooling and processing of extrudates  2020  276861  PhD Zoran Lavrič     Package 17 
16. Mass spectrometer (MS)  2015  96016  PhD Janez Ilaš   Analytical facilities  Programs, projects and commercial resources 
17. Pan Coatear GMPC I  2014  76110  PhD Rok Dreu   Research facilities  Projects, programs and other public resources 
18. Photon correlation spectroscopy and laser Doppler electrophoresis (Zetasizer Ultra)  2020  67472  PhD Pegi Ahlin Grabnar   Analytical facilities  Programs, projects and commercial resources 
19. Reometer - Anton Paar  2011  92557  PhD Saša Baumgartner   Research facilities  Projects, programs and other public resources 
20. SOTAX CE 7 smart DISSOTEST ON/OFF-LINE  2007  100836  PhD Marija Bogataj   Analytical facilities  Package 13 
21. System for electrostatic spinning of nanofibers   2015  102271  PhD Zoran Lavrič   Research facilities  Programs, projects and commercial resources 
22. Transgenomic WAVE MD dHPLC SISTEM Plus  2007  103320  PhD Janja Marc   Genomic, transcriptomic, proteomics and metabolomics facilities  Package 13 
23. UHPLC-MS/MS Liquid chromatograph coupled to mass detector triple quadrupole/linear ion trap. Agilent 1290 Infinity II / Sciex QTRAP 5500+  2020  281298  PhD Jurij Trontelj     Package 18 
24. UHPLC system coupled to DAD and CAD detector  2020  149851  PhD Stane Pajk     Package 18 
25. Ultra centrifuga WX 100, Sorvall (Thermo Fischer scientific)  2011  96037  PhD Petra Kocbek   Research facilities  Projects, programs and other public resources 
26. Ultra high preasure liquid chromatograph with triple quadrupole tandem mass spectrometer (LC/MS/MS) Agilent 6460  2010  376685  PhD Jurij Trontelj   Analytical facilities  Package 14 
Mentors for junior researchers (36)
no. Code Name and surname Research area Status
1. 00035  PhD Dušan Hadži  Chemistry  Researcher 
2. 00831  PhD Jelka Šmid-Korbar  Pharmacy  Researcher 
3. 00839  PhD Aleš Krbavčič  Pharmacy  Researcher 
4. 01463  PhD Danijel Kikelj  Pharmacy  Researcher 
5. 01466  PhD Vojko Kmetec  Pharmacy  Researcher 
6. 01878  PhD Uroš Urleb  Pharmacy  Researcher 
7. 03070  PhD Slavko Pečar  Pharmacy  Researcher 
8. 04648  PhD Janko Kos  Biotechnical sciences  Researcher 
9. 06086  PhD Aleš Mrhar  Pharmacy  Researcher 
10. 07849  PhD Borut Štrukelj  Biochemistry and molecular biology  Researcher 
11. 08519  PhD Marija Sollner Dolenc  Pharmacy  Researcher 
12. 09031  PhD Stanko Srčič  Pharmacy  Researcher 
13. 09032  PhD Julijana Kristl  Pharmacy  Researcher 
14. 09066  PhD Stanislav Primožič  Pharmacy  Researcher 
15. 11122  PhD Albin Kristl  Pharmacy  Researcher 
16. 11124  PhD Marija Bogataj  Pharmacy  Researcher 
17. 11789  PhD Mirjana Gašperlin  Pharmacy  Researcher 
18. 12189  PhD Janja Marc  Metabolic and hormonal disorders  Researcher 
19. 12443  PhD Irena Mlinarič Raščan  Pharmacy  Researcher 
20. 14935  PhD Odon Planinšek  Pharmacy  Researcher 
21. 15284  PhD Stanislav Gobec  Pharmacy  Researcher 
22. 15460  PhD Samo Kreft  Pharmacy  Researcher 
23. 18154  PhD Barbara Ostanek  Metabolic and hormonal disorders  Researcher 
24. 18155  PhD Tomaž Vovk  Pharmacy  Researcher 
25. 18633  PhD Anamarija Zega  Pharmacy  Researcher 
26. 19281  PhD Zdenko Časar  Chemistry  Researcher 
27. 19317  PhD Lucija Peterlin Mašič  Pharmacy  Researcher 
28. 20374  PhD Mitja Kos  Pharmacy  Researcher 
29. 23420  PhD Jurij Trontelj  Pharmacy  Researcher 
30. 24400  PhD Janez Ilaš  Pharmacy  Researcher 
31. 24402  PhD Petra Kocbek  Pharmacy  Researcher 
32. 25490  PhD Matej Sova  Pharmacy  Researcher 
33. 26496  PhD Žiga Jakopin  Pharmacy  Researcher 
34. 26512  PhD Rok Frlan  Pharmacy  Researcher 
35. 28334  PhD Tihomir Tomašić  Pharmacy  Researcher 
36. 30816  PhD Izidor Sosič  Pharmacy  Researcher 
Description
The faculty's basic activity is pedagogical which comprises university program in pharmacy and a three-year program in clinical biochemistry. Within its scientific-research work, the faculty is engaged in researching and discovering new compounds, technologies, therapeutic systems as well as in gaining new knowledge, methodology and procedures in all phases of production and evaluation of a new medicine by considering professional standards (procedure validation, authority (state) requirements to medicine manufacturers within the principles of GLP (good laboratory practice), GMP (good manufacture practice) and GPP (good pharmacy practice). By its scientific-research work the faculty takes part in the development and strategic plans of the national pharmaceutical industry as well as in global research trends through international projects in the field of pharmacy. The main strategic goals of the faculty's further scientific-research development are: - researching and discovering new selective ligands for receptors and enzymes as well as new biocompatible materials which may become a future starting point for developing new substances and new pharmaceutical forms, respectively. - creating new knowledge and inventing new means and methods of compounds' characterization considering transportation and distribution of substances in models and biosystems of growing complexity, as well from the viewpoint of ligand-receptor interactions. - researching new therapeutic systems with designed properties. - researching new specific diagnostic tests and other methods for simulation and control of therapy. - researching optimal pharmacoepidemiologic and pharmacoeconomic parameters and new therapeutic approaches.
Views history
Favourite